You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vandetanib

Showing 26 - 50 of 118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Cancer Trial in Worldwide (ZD6474 (Vandetanib))

Active, not recruiting
Has Results
  • Thyroid Cancer
  • ZD6474 (Vandetanib)
  • Little Rock, Arkansas
  • +65 more
Oct 20, 2021

Children and Adults With Medullary Thyroid Cancer

Recruiting
  • Medullary Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 7, 2022

    Lung Cancer Trial in Detroit (carboplatin, paclitaxel, Zactima)

    Terminated
    Has Results
    • Lung Cancer
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Mar 13, 2019

    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Ureter Cancer Trial in United Kingdom (carboplatin,

    Completed
    • Bladder Cancer
    • +3 more
    • Glasgow, Scotland, United Kingdom
    • +20 more
    May 14, 2019

    Renal Cancer, Von Hippel Lindau Trial run by the NCI (ZACTIMA (Vandetanib) (ZD6474))

    Completed
    Has Results
    • Renal Cancer
    • Von Hippel Lindau
    • ZACTIMA (Vandetanib) (ZD6474)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 2, 2018

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Glioblastoma Multiforme, Gliosarcoma Trial in United States (ZD6474, temozolomide, Radiation Therapy)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • Gliosarcoma
    • Boston, Massachusetts
    • +6 more
    Feb 14, 2019

    Medullary Thyroid Carcinoma Trial run by the NCI (Bortezomib, Vandetanib)

    Terminated
    Has Results
    • Medullary Thyroid Carcinoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 5, 2018

    Transitional Cell Carcinoma, Bladder Cancer Trial in Boston (Docetaxel, vandetanib, Placebo)

    Completed
    Has Results
    • Transitional Cell Carcinoma
    • Bladder Cancer
    • Boston, Massachusetts
    • +2 more
    Aug 20, 2018

    Metastatic Cancer Trial in Lillestrøm, Oslo (EMA-approved ATI based targeted therapy)

    Completed
    • Metastatic Cancer
    • EMA-approved ATI based targeted therapy
    • Lillestrøm, Norway
    • +1 more
    Mar 12, 2019

    Cancer Target Therapy Efficacy

    Active, not recruiting
    • Cancer
    • RNA sequencing
    • +5 more
    • Walnut, California
    • +6 more
    Sep 13, 2021

    Medullary Thyroid Cancer Trial (Ponatinib)

    Withdrawn
    • Medullary Thyroid Cancer
    • (no location specified)
    Oct 6, 2021

    NSCLC Trial in Houston (ZD6474 (ZACTIMA), Radiation Therapy)

    Terminated
    • Non-Small Cell Lung Cancer
    • ZD6474 (ZACTIMA)
    • Radiation Therapy
    • Houston, Texas
      UT MD Anderson Cancer Center
    Nov 12, 2018

    Lung Cancer, Non Small Cell Lung Cancer Trial in United States (vandetanib induction, Docetaxel, Carboplatin)

    Completed
    Has Results
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • vandetanib induction
    • +4 more
    • Boca Raton, Florida
    • +29 more
    Apr 30, 2018

    Diffuse Intrinsic Pontine Glioma Trial in Milan (Nimotuzumab, Vinorelbine, Radiotherapy)

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    Sep 3, 2021

    Thyroid Cancer Trial in France, United States (ZD6474 (vandetanib))

    Completed
    Has Results
    • Thyroid Cancer
    • ZD6474 (vandetanib)
    • San Francisco, California
    • +5 more
    Apr 6, 2018

    Colorectal, Cancer Trial in Worldwide (Vandetanib, FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid)

    Completed
    Has Results
    • Colorectal
    • Cancer
    • Vandetanib
    • FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid
    • Lille Cedex, France
    • +14 more
    Jan 24, 2018

    Medullary Thyroid Cancer, Colon Cancer Trial in New York (Tumor Genomic Analysis)

    Suspended
    • Medullary Thyroid Cancer
    • Colon Cancer
    • Tumor Genomic Analysis
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 14, 2020

    Medullary Thyroid Cancer (MTC) Trial run by the (GI-6207 [Recombinant Saccharomyces cerevisiae-CEA (610D)])

    Unknown status
    • Medullary Thyroid Cancer (MTC)
    • GI-6207 [Recombinant Saccharomyces cerevisiae-CEA (610D)]
    • Bethesda, Maryland
      NIH Clinical Center
    Oct 22, 2019

    Cardiac Complication, Vascular Diseases Trial in Paris (Cardiac complication induced by VEGF/VEGFR inhibitor)

    Completed
    • Cardiac Complication
    • Vascular Diseases
    • Cardiac complication induced by VEGF/VEGFR inhibitor
    • Paris, France
      AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
    Sep 24, 2019

    Medullary Thyroid Cancer Trial in Overland Park (vandetanib, omeprazole, ranitidine)

    Completed
    • Medullary Thyroid Cancer
    • vandetanib
    • +2 more
    • Overland Park, Kansas
      Research Site
    Apr 28, 2017

    Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Tumors Trial run by the NCI (75 approved agents, COXEN)

    Completed
    Has Results
    • Urothelial Carcinoma
    • +2 more
    • 75 approved agents
    • COXEN
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 14, 2020

    Breast Cancer, Head Neck Cancer, Lung Cancer Trial (drug, genetic, other)

    Withdrawn
    • Breast Cancer
    • +4 more
    • (no location specified)
    Apr 20, 2017

    Metastatic Medullary Thyroid Cancer Trial in Belgium (Caprelsa)

    Completed
    • Metastatic Medullary Thyroid Cancer
    • Arlon, Belgium
    • +7 more
    Apr 28, 2017

    Non Small Cell Lung Cancer Trial in Italy (Cabozantinib 20 MG, Cabozantinib 40 MG, Cabozantinib 60 MG)

    Recruiting
    • Non Small Cell Lung Cancer
    • Cabozantinib 20 MG
    • +2 more
    • Bologna, Italy
    • +10 more
    Oct 17, 2019